Express Scripts Holding Company Company Profile (NASDAQ:ESRX)

About Express Scripts Holding Company (NASDAQ:ESRX)

Express Scripts Holding Company logoExpress Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:ESRX
  • CUSIP: 30219G10
  • Web: www.express-scripts.com
Capitalization:
  • Market Cap: $34.37 billion
  • Outstanding Shares: 577,549,000
Average Prices:
  • 50 Day Moving Avg: $61.36
  • 200 Day Moving Avg: $62.17
  • 52 Week Range: $55.80 - $77.50
P/E:
  • Trailing P/E Ratio: 10.33
  • Foreward P/E Ratio: 7.76
  • P/E Growth: 0.69
Sales & Book Value:
  • Annual Revenue: $100.28 billion
  • Price / Sales: 0.34
  • Book Value: $27.26 per share
  • Price / Book: 2.18
Profitability:
  • EBITDA: $7.16 billion
  • Net Margins: 3.50%
  • Return on Equity: 25.58%
  • Return on Assets: 7.96%
Debt:
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 0.69%
  • Quick Ratio: 0.58%
Misc:
  • Average Volume: 3.41 million shs.
  • Beta: 0.88
  • Short Ratio: 9.82
 

Frequently Asked Questions for Express Scripts Holding Company (NASDAQ:ESRX)

What is Express Scripts Holding Company's stock symbol?

Express Scripts Holding Company trades on the NASDAQ under the ticker symbol "ESRX."

How were Express Scripts Holding Company's earnings last quarter?

Express Scripts Holding Company (NASDAQ:ESRX) released its quarterly earnings data on Tuesday, July, 25th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. The firm earned $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding Company had a return on equity of 25.58% and a net margin of 3.50%. The firm's quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.57 earnings per share. View Express Scripts Holding Company's Earnings History.

When will Express Scripts Holding Company make its next earnings announcement?

Express Scripts Holding Company is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Express Scripts Holding Company.

What guidance has Express Scripts Holding Company issued on next quarter's earnings?

Express Scripts Holding Company updated its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share (EPS) guidance of $6.95-7.05 for the period, compared to the Thomson Reuters consensus estimate of $6.97. Express Scripts Holding Company also updated its Q3 guidance to $1.88-1.92 EPS.

Where is Express Scripts Holding Company's stock going? Where will Express Scripts Holding Company's stock price be in 2017?

20 brokerages have issued 1-year target prices for Express Scripts Holding Company's shares. Their forecasts range from $56.00 to $85.00. On average, they anticipate Express Scripts Holding Company's share price to reach $68.50 in the next year. View Analyst Ratings for Express Scripts Holding Company.

What are analysts saying about Express Scripts Holding Company stock?

Here are some recent quotes from research analysts about Express Scripts Holding Company stock:

  • 1. According to Zacks Investment Research, "We are upbeat about Express Scripts’ pharmacy-benefits management long-term outlook. The projection takes the volatile healthcare market trends, inflation, patent expiration and lower industry utilization growth into consideration. Furthermore, Express Scripts should benefit from increased generic utilization, shift toward mail orders, strong specialty growth and an aging population. Branded drugs are becoming increasingly expensive due to double-digit brand inflation. Thus, continued rise in the price of specialty drugs and overwhelming regulatory burden is opening up considerable prospects for generics. However, over the past one year, Express Scripts has underperformed the broader industry in terms of price. Tough competition in the niche space and the persistent drug pricing issue are anticipated to affect the stock." (10/16/2017)
  • 2. Jefferies Group LLC analysts commented, "We believe ESRX remains a Buy given our view that company fundamentals, including its FCF, are stable and that the stock's valuation is attractive at 9x FY18 P/E. That said, we recognize that headlines surrounding drug pricing pressure and the overhang from ESRX's Anthem contract will drive continued stock volatility NT." (2/17/2017)

Are investors shorting Express Scripts Holding Company?

Express Scripts Holding Company saw a increase in short interest in September. As of September 29th, there was short interest totalling 32,966,022 shares, an increase of 3.9% from the September 15th total of 34,319,116 shares. Based on an average trading volume of 3,654,812 shares, the short-interest ratio is currently 9.0 days. Approximately 5.7% of the shares of the company are sold short.

Who are some of Express Scripts Holding Company's key competitors?

Who owns Express Scripts Holding Company stock?

Express Scripts Holding Company's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include APG Asset Management N.V. (0.29%), PGGM Investments (0.18%), Strs Ohio (0.06%), Fisher Asset Management LLC (0.06%), Robeco Institutional Asset Management B.V. (0.06%) and State Treasurer State of Michigan (0.03%). Company insiders that own Express Scripts Holding Company stock include Christopher A Mcginnis, Everett Neville, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr. View Institutional Ownership Trends for Express Scripts Holding Company.

Who sold Express Scripts Holding Company stock? Who is selling Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Strs Ohio, Bridges Investment Counsel Inc., Assenagon Asset Management S.A., State Treasurer State of Michigan, First National Bank of Mount Dora Trust Investment Services, Bridges Investment Management Inc. and Quantitative Systematic Strategies LLC. Company insiders that have sold Express Scripts Holding Company stock in the last year include Everett Neville, Phyllis S Anderson and Woodrow A Myers Jr. View Insider Buying and Selling for Express Scripts Holding Company.

Who bought Express Scripts Holding Company stock? Who is buying Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was bought by a variety of institutional investors in the last quarter, including PGGM Investments, Shell Asset Management Co., Robeco Institutional Asset Management B.V., Fisher Asset Management LLC, BerganKDV Wealth Management LLC, Eqis Capital Management Inc., Balasa Dinverno & Foltz LLC and Summit X LLC. View Insider Buying and Selling for Express Scripts Holding Company.

How do I buy Express Scripts Holding Company stock?

Shares of Express Scripts Holding Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Express Scripts Holding Company's stock price today?

One share of Express Scripts Holding Company stock can currently be purchased for approximately $59.51.


MarketBeat Community Rating for Express Scripts Holding Company (NASDAQ ESRX)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  645 (Vote Outperform)
Underperform Votes:  434 (Vote Underperform)
Total Votes:  1,079
MarketBeat's community ratings are surveys of what our community members think about Express Scripts Holding Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Express Scripts Holding Company (NASDAQ:ESRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Sell Ratings, 11 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.05)
Consensus Price Target: $68.50 (15.11% upside)
Consensus Price Target History for Express Scripts Holding Company (NASDAQ:ESRX)
Price Target History for Express Scripts Holding Company (NASDAQ:ESRX)
Analysts' Ratings History for Express Scripts Holding Company (NASDAQ:ESRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/9/2017Raymond James Financial, Inc.Reiterated RatingMarket Perform -> UnderperformN/AView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$68.00HighView Rating Details
9/1/2017Robert W. BairdReiterated RatingHold$56.00MediumView Rating Details
8/29/2017Jefferies Group LLCSet Price TargetBuy$72.00LowView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$52.00 -> $57.00LowView Rating Details
7/21/2017Needham & Company LLCInitiated CoverageHold -> HoldLowView Rating Details
6/9/2017Cowen and CompanyReiterated RatingOutperform$83.00LowView Rating Details
4/26/2017Evercore ISILower Price TargetIn-Line$68.50 -> $59.00MediumView Rating Details
4/26/2017Edward JonesDowngradeBuy -> HoldHighView Rating Details
4/25/2017SunTrust Banks, Inc.Reiterated RatingBuyHighView Rating Details
4/25/2017Bank of America CorporationReiterated RatingNeutral$77.00HighView Rating Details
4/25/2017MizuhoLower Price TargetNeutral -> Neutral$76.00 -> $61.00HighView Rating Details
3/29/2017ArgusReiterated RatingHoldLowView Rating Details
3/15/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformLowView Rating Details
3/8/2017Leerink SwannReiterated RatingMarket Perform$75.00LowView Rating Details
2/16/2017Credit Suisse GroupReiterated RatingBuy$85.00N/AView Rating Details
2/14/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldN/AView Rating Details
12/16/2016Barclays PLCReiterated RatingOverweightN/AView Rating Details
12/1/2016Sanford C. BernsteinReiterated RatingUnderperform$59.00N/AView Rating Details
11/3/2016Deutsche Bank AGUpgradeSell -> Hold$69.00 -> $70.00N/AView Rating Details
6/1/2016WedbushReiterated RatingNeutralN/AView Rating Details
5/24/2016Citigroup Inc.Reiterated RatingBuyN/AView Rating Details
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00N/AView Rating Details
3/18/2016William BlairReiterated RatingBuyN/AView Rating Details
2/18/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$82.00 -> $74.00N/AView Rating Details
2/17/2016Maxim GroupReiterated RatingBuy$109.00 -> $95.00N/AView Rating Details
12/23/2015BMO Capital MarketsBoost Price TargetMarket Perform$94.00N/AView Rating Details
11/29/2015J P Morgan Chase & CoReiterated RatingBuy$105.00N/AView Rating Details
(Data available from 10/23/2015 forward)

Earnings

Earnings History for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings History by Quarter for Express Scripts Holding Company (NASDAQ ESRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$1.89N/AView Earnings Details
7/25/2017Q2 2017$1.71$1.73$25.52 billion$25.35 billionViewN/AView Earnings Details
4/24/2017Q1 17$1.32$1.33$24.95 billion$24.65 billionViewN/AView Earnings Details
2/14/2017Q4 2016$1.87$1.88$26.31 billion$24.90 billionViewListenView Earnings Details
10/25/2016Q3$1.74$1.74$25.48 billion$25.41 billionViewListenView Earnings Details
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details
7/28/2015Q215$1.40$1.44$26.13 billion$25.45 billionViewListenView Earnings Details
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details
7/29/2014Q214$1.22$1.23$24.42 billion$25.11 billionViewListenView Earnings Details
4/29/2014Q114$1.01$0.99$23.81 billion$23.69 billionViewListenView Earnings Details
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details
10/25/2013Q313$1.08$1.08$25.01 billion$25.92 billionViewListenView Earnings Details
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.06 billionViewListenView Earnings Details
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details
8/7/2012$0.82$0.88ViewN/AView Earnings Details
5/10/2012$0.77$0.73ViewN/AView Earnings Details
2/22/2012$0.85$0.82ViewN/AView Earnings Details
10/25/2011$0.77$0.79ViewN/AView Earnings Details
7/21/2011$0.69$0.71ViewN/AView Earnings Details
4/26/2011$0.69$0.66ViewN/AView Earnings Details
2/16/2011$0.70$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)
2017 EPS Consensus Estimate: $6.98
2018 EPS Consensus Estimate: $7.63
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$1.31$1.33$1.32
Q2 20175$1.68$1.72$1.70
Q3 20175$1.90$1.91$1.90
Q4 20175$2.03$2.07$2.05
Q1 20184$1.45$1.52$1.49
Q2 20184$1.85$1.92$1.88
Q3 20184$2.02$2.09$2.05
Q4 20184$2.16$2.26$2.21
Q1 20191$1.59$1.59$1.59
Q2 20191$2.01$2.01$2.01
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Express Scripts Holding Company (NASDAQ:ESRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Ownership Percentage: 0.68%
Institutional Ownership Percentage: 88.69%
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2017Woodrow A Myers JrDirectorSell3,900$63.93$249,327.00View SEC Filing  
9/8/2017Phyllis S AndersonVPSell578$63.13$36,489.14View SEC Filing  
8/23/2017Everett NevilleVPSell1,163$61.48$71,501.24View SEC Filing  
5/19/2017Phyllis S AndersonVPSell1,100$60.08$66,088.00View SEC Filing  
3/1/2017Everett NevilleSVPSell2,352$70.16$165,016.32View SEC Filing  
1/3/2017Everett NevilleVPSell1,123$69.41$77,947.43View SEC Filing  
9/14/2016Woodrow A Myers JrDirectorSell12,036$70.40$847,334.40View SEC Filing  
9/12/2016Christopher A McginnisVPSell1,785$70.77$126,324.45View SEC Filing  
5/10/2016Everett NevilleVPSell800$74.11$59,288.00View SEC Filing  
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.26View SEC Filing  
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.24View SEC Filing  
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.96View SEC Filing  
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.00View SEC Filing  
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.49View SEC Filing  
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.00View SEC Filing  
3/10/2014Steven MillerVPSell12,664$77.96$987,285.44View SEC Filing  
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.43View SEC Filing  
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.00View SEC Filing  
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.00View SEC Filing  
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.20View SEC Filing  
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.48View SEC Filing  
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Express Scripts Holding Company (NASDAQ:ESRX)
Latest Headlines for Express Scripts Holding Company (NASDAQ:ESRX)
Source:
Loading headlines, please wait.

Social

Chart

Express Scripts Holding Company (ESRX) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.